Publicaciones en colaboración con investigadores/as de Ogaki Municipal Hospital (2)

2025

  1. Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

    The New England journal of medicine, Vol. 392, Núm. 18, pp. 1777-1788

2019

  1. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458